Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Arlett

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Plos One|October 20, 2022
A natural language processing approach towards harmonisation of European medicinal product informationErik Bergman, Kim Sherwood, Markus Forslund, et al.
Drug Safety|July 24, 2017
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System WorksAniello Santoro, Georgy Genov, Almath Spooner, et al.
Drug Safety|March 5, 2016
Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error PreventionThomas Goedecke, Kathryn Ord, Victoria Newbould, et al.
Nature Reviews. Drug Discovery|November 21, 2022
Artificial intelligence in European medicines regulationPhilip A Hines, Ralf Herold, Luis Pinheiro, et al.
The Lancet. Infectious Diseases|February 26, 2022
COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in EuropeEdit Szepessy, Peter Arlett, Fergus Sweeney, et al.
Pharmacoepidemiology and Drug Safety|November 17, 2017
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilanceLuis C Pinheiro, Gianmario Candore, Cosimo Zaccaria, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilanceLuis Pinheiro, Kevin Blake, Justina Januskiene, et al.
Clinical Pharmacology and Therapeutics|October 18, 2019
Improving the Safety of Medicines in the European Union: From Signals to ActionJoanne Potts, Georgy Genov, Andrej Segec, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in ChildrenGianmario Candore, Karin Hedenmalm, Jim Slattery, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2012
Increasing scientific standards, independence and transparency in post-authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and PharmacovigilanceKevin V Blake, Corinne S Devries, Peter Arlett, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Plos One|October 20, 2022
A natural language processing approach towards harmonisation of European medicinal product informationErik Bergman, Kim Sherwood, Markus Forslund, et al.
Drug Safety|July 24, 2017
Promoting and Protecting Public Health: How the European Union Pharmacovigilance System WorksAniello Santoro, Georgy Genov, Almath Spooner, et al.
Drug Safety|March 5, 2016
Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error PreventionThomas Goedecke, Kathryn Ord, Victoria Newbould, et al.
Nature Reviews. Drug Discovery|November 21, 2022
Artificial intelligence in European medicines regulationPhilip A Hines, Ralf Herold, Luis Pinheiro, et al.
The Lancet. Infectious Diseases|February 26, 2022
COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in EuropeEdit Szepessy, Peter Arlett, Fergus Sweeney, et al.
Pharmacoepidemiology and Drug Safety|November 17, 2017
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilanceLuis C Pinheiro, Gianmario Candore, Cosimo Zaccaria, et al.
Pharmacoepidemiology and Drug Safety|March 24, 2016
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilanceLuis Pinheiro, Kevin Blake, Justina Januskiene, et al.
Clinical Pharmacology and Therapeutics|October 18, 2019
Improving the Safety of Medicines in the European Union: From Signals to ActionJoanne Potts, Georgy Genov, Andrej Segec, et al.
Clinical Pharmacology and Therapeutics|January 21, 2020
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in ChildrenGianmario Candore, Karin Hedenmalm, Jim Slattery, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2012
Increasing scientific standards, independence and transparency in post-authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and PharmacovigilanceKevin V Blake, Corinne S Devries, Peter Arlett, et al.
Pageof 6